Renoprotective effect of berberine via intonation on apoptosis and mitochondrial-dependent pathway in renal ischemia reperfusion-induced mutilation

Renal Failure

Volumn 37, Issue 3, 2015, Pages 482-493

  Visnagri, Asjad ^a   Kandhare, Amit D ^a   Bodhankar, Subhash L ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Bax; Bcl 2; Berberine; Caspase 3; Cytochrome oxidase; KIM 1; NGAL; Renal ischemia reperfusion; TNF

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BERBERINE; CASPASE 3; CREATININE; GLUTATHIONE; KIDNEY INJURY MOLECULE 1; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; PROTECTIVE AGENT; TNF PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART VENTRICLE CONTRACTILITY; INCISION; INVESTIGATIVE PROCEDURES; KIDNEY ARTERY STENOSIS; KIDNEY ISCHEMIA; MALE; MEAN ARTERIAL PRESSURE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL ISCHEMIA REPERFUSION; RENAL PROTECTION; REPERFUSION; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; UNINEPHRECTOMY; UREA NITROGEN BLOOD LEVEL; WISTAR RAT; ACUTE KIDNEY FAILURE; ANIMAL; BLOOD; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ISCHEMIA; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; REPERFUSION INJURY; TREATMENT OUTCOME; VASCULARIZATION;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BERBERINE; BIOMARKERS; CASPASE 3; CREATININE; DISEASE MODELS, ANIMAL; ISCHEMIA; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MITOCHONDRIA; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929096324     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2014.996843     Document Type: Article

References (78)

1. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365-3370.
2. Weinberg JM. The cell biology of ischemic renal injury. Kidney Int. 1991;39:476-500.
3. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 1984;74:1156-1164.
4. Myers SI, Wang L, Liu F, Bartula LL. Oxygen-radical regulation of renal blood flow following suprarenal aortic clamping. J Vasc Surg. 2006;43:577-586.
5. Gill N, Nally JV, Fatica RA. Renal failure secondary to acute tubular necrosis epidemiology, diagnosis, and management. CHEST J. 2005;128:2847-2863.
6. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: Definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004;114:5-14.
7. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 2003;14: 2199-2210.
8. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996;334:1448-1460.
9. Gosavi T, Kandhare A, Raygude K, Ghosh P, Bodhankar S. A comparative study on the efficacy, safety and cost effectiveness of Viscum album and Rauwolfia serpentina mother tincture in hypertensive patients. Deccan J Nat Prod. 2011;2:29-35.
10. Lieberthal W, Levine JS. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol Renal Physiol. 1996;271:F477-F488.
11. Paller MS. The cell biology of reperfusion injury in the kidney. J Invest Med. 1994;42:632-639.
12. Birdsall TC, Kelly GS. Berberine: Therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev. 1997;2: 94-103.
13. Pereira CV, Machado NG, Oliveira PJ. Mechanisms of berberine (natural yellow 18)-induced mitochondrial dysfunction: Interaction with the adenine nucleotide translocator. Toxicol Sci. 2008;105: 408-417.
14. Vuddanda PR, Chakraborty S, Singh S. Berberine: A potential phytochemical with multispectrum therapeutic activities. Exp Opin Invest Drugs. 2010;19:1297-1307.
15. Dong S-F, Hong Y, Liu M, et al. Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats. Eur J Pharmacol. 2011;660:368-374.
16. Hong Y, Hui SS, Chan BT, Hou J. Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy. Life Sci. 2003;72:2499-2507.
17. Xu M-G, Wang J-M, Chen L, Wang Y, Yang Z, Tao J. Berberineinduced upregulation of circulating endothelial progenitor cells is related to nitric oxide production in healthy subjects. Cardiology. 2008;112:279-286.
18. Zeng X-H, Zeng X-J, Li Y-Y. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2003;92:173-176.
19. Lee S, Lim H-J, Park H-Y, Lee K-S, Park J-H, Jang Y. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo: Berberine improves neointima formation in a rat model. Atherosclerosis. 2006;186:29-37.
20. Tang L, Lv F, Liu S, Zhang S. Effect of berberine on expression of transforming growth factor-beta1 and type IV collagen proteins in mesangial cells of diabetic rats with nephropathy. Zhongguo Zhong Yao Za Zhi. 2011;36:3494-3497.
21. Tang LQ, Wang FL, Zhu LN, Lv F, Liu S, Zhang ST. Berberine ameliorates renal injury by regulating G proteins-AC-cAMP signaling in diabetic rats with nephropathy. Mol Biol Rep. 2013;40: 3913-3923.
22. Yu W, Sheng M, Xu R, Yu J, Cui K, Tong J, et al. Berberine protects human renal proximal tubular cells from hypoxia/ reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways. J Transl Med. 2013;11:24-34.
23. Kandhare AD, Ghosh P, Bodhankar SL. Naringin, a flavanone glycoside, promotes angiogenesis and inhibits endothelial apoptosis through modulation of inflammatory and growth factor expression in diabetic foot ulcer in rats. Chem Biol Interact. 2014;219C: 101-112.
24. Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL. Elucidation of molecular mechanism involved in neuroprotective effect of Coenzyme Q10 in alcohol induced neuropathic pain. Fundam Clin Pharmacol. 2013;27:603-622.
25. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 1996;74:86-107.
26. Wei Q, Wang MH, Dong Z. Differential gender differences in ischemic and nephrotoxic acute renal failure. Am J Nephrol. 2005; 25:491-499.
27. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: A tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol. 2004;286: F552-F563.
28. Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia. 2012;83:650-659.
29. Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Therapeutic role of curcumin in prevention of biochemical and behavioral aberration induced by alcoholic neuropathy in laboratory animals. Neurosci Lett. 2012;511:18-22.
30. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/Life regulator in apoptosis and necrosis. Annu Rev Physiol. 1998;60:619-642.
31. Willinger CC, Schramek H, Pfaller K, Pfaller W. Tissue distribution of neutrophils in postischemic acute renal failure. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;62:237-243.
32. Visnagri A, Kandhare AD, Ghosh P, Bodhankar SL. Endothelin receptor blocker bosentan inhibits hypertensive cardiac fibrosis in pressure overload-induced cardiac hypertrophy in rats. Cardiovasc Endocrinol. 2013;2:85-97.
33. Kandhare AD, Raygude KS, Shiva Kumar V, et al. Ameliorative effects quercetin against impaired motor nerve function, inflammatory mediators and apoptosis in neonatal streptozotocin-induced diabetic neuropathy in rats. Biomed Aging Pathol. 2012;2:173-186.
34. Kandhare AD, Bodhankar SL, Singh V, Mohan V, Thakurdesai PA. Anti-asthmatic effects of type-A procyanidine polyphenols from cinnamon bark in ovalbumin-induced airway hyperresponsiveness in laboratory animals. Biomed Aging Pathol. 2013;3:23-30.
35. Kandhare A, Raygude K, Ghosh P, Bodhankar S. The ameliorative effect of fisetin, a bioflavonoid, on ethanol-induced and pylorus ligation-induced gastric ulcer in rats. Int J Green Pharm. 2011;5: 236-243.
36. Kandhare AD, Ghosh P, Ghule AE, Zambare GN, Bodhankar SL. Protective effect of Phyllanthus amarus by modulation of endogenous biomarkers and DNA damage in acetic acid induced ulcerative colitis: Role of phyllanthin and hypophyllanthin. Apollo Med. 2013; 10:87-97.
37. Rosenthal RE, Hamud F, Fiskum G, Varghese PJ, Sharpe S. Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. J Cereb Blood Flow Metab. 1987;7: 752-758.
38. Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A. An electron-transport system associated with the outer membrane of liver mitochondria a biochemical and morphological study. J Cell Biol. 1967;32:415-438.
39. Kandhare AD, Shivakumar V, Rajmane A, Ghosh P, Bodhankar SL. Evaluation of the neuroprotective effect of chrysin via modulation of endogenous biomarkers in a rat model of spinal cord injury. J Nat Med. 2014;68(3):586-603.
40. Visnagri A, Kandhare AD, Chakravarty S, Ghosh P, Bodhankar SL. Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions. Pharm Biol. 2014;52:814-828.
41. Ghosh P, Kandhare AD, Raygude KS, et al. Determination of the long term diabetes related complications and cardiovascular events using UKPDS risk engine and UKPDS outcomes model in a representative western Indian population. Asian Pac J Trop Dis. 2012;2:S642-S650.
42. Kamble H, Kandhare AD, Bodhankar S, Mohan V, Thakurdesai P. Effect of low molecular weight galactomannans from fenugreek seeds on animal models of diabetes mellitus. Biomed Aging Pathol. 2013;3:145-151.
43. Mejia-Vilet JM, Ramirez V, Cruz C, Uribe N, Gamba G, Bobadilla NA. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol. 2007;293:F78-F86.
44. Cotran R, Rennke M, Kumar V. The kidney and its collecting system. In: Robbins SL, Kumar V, eds. Basic Pathology. Philadelphia: WB Saunders Company; 1987:457-491.
45. Pickering TG, Mann S. Renovascular hypertension: Medical evaluation and nonsurgical treatment. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York: Raven Press; 1990:2-14.
46. Forbes JM, Hewitson TD, Becker GJ, Jones CL. Ischemic acute renal failure: Long-term histology of cell and matrix changes in the rat. Kidney Int. 2000;57:2375-2385.
47. Korkmaz A, Kolankaya D. Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney. J Surg Res. 2010;164:309-315.
48. Hagiwara S, Koga H, Iwasaka H, et al. ETS-GS, a new antioxidant, ameliorates renal ischemia-reperfusion injury in a rodent model. J Surg Res. 2011;171:226-233.
49. Aunapuu M, Pechter U, Kuhnel W, Ots M, Arend A. Morphological changes in experimental postischemic rat kidney. A pilot study. Ann Anat. 2005;187:63-70.
50. Liu JC, Chan P, Chen YJ, Tomlinson B, Hong SH, Cheng JT. The antihypertensive effect of the berberine derivative 6-protoberberine in spontaneously hypertensive rats. Pharmacology. 1999;59: 283-289.
51. Kumar VS, Rajmane AR, Adil M, Kandhare AD, Ghosh P, Bodhankar SL. Naringin ameliorates acetic acid induced colitis through modulation of endogenous oxido-nitrosative balance and DNA damage in rats. J Biomed Res. 2014;28:132-145.
52. Raygude KS, Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL. Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats. Inflammopharmacology. 2012;20:331-341.
53. Mizuno S, Nakamura T. Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol. 2005;166:1895-1905.
54. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol. 2008;109:e102-e107.
55. Lieberthal W, Koh JS, Levine JS. Necrosis and apoptosis in acute renal failure. Semin Nephrol. 1998;18:505-518.
56. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14: 2534-2543.
57. Gaspari F, Cravedi P, Mandalà M, et al. Predicting cisplatininduced acute kidney injury by urinary neutrophil gelatinaseassociated lipocalin excretion: A pilot prospective case-control study. Nephron Clin Pract. 2010;115:c154-c160.
58. Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalinsiderophore-iron complex rescues the kidney from ischemiareperfusion injury. J Clin Invest. 2005;115:610-621.
59. Huynh TK, Bateman DA, Parravicini E, et al. Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr Res. 2009;66:528-532.
60. Haase-Fielitz A, Bellomo R, Devarajan P, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-A prospective cohort study. Crit Care Med. 2009;37:553-560.
61. Carlson M, Raab Y, Seveus L, Xu S, Hällgren R, Venge P. Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut. 2002;50:501-506.
62. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62:237-244.
63. Olivetti G, Quaini F, Sala R, et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol. 1996;28:2005-2016.
64. Waller HL, Harper SJ, Hosgood SA, et al. Differential expression of cytoprotective and apoptotic genes in an ischemia-reperfusion isolated organ perfusion model of the transplanted kidney. Transpl Int. 2007;20:625-631.
65. Mattana J, Kochlatyi S, Gibbons N. Metal-catalyzed oxidation of extracellular matrix proteins promotes human mesangial cell apoptosis and is associated with enhanced expression of Bax and caspase activation. Biochem Biophys Res Commun. 2002;292: 652-658.
66. Yang B, Jain S, Ashra SY, Furness PN, Nicholson ML. Apoptosis and caspase-3 in long-term renal ischemia/reperfusion injury in rats and divergent effects of immunosuppressants. Transplantation. 2006;81:1442-1450.
67. Kunduzova OR, Escourrou G, Seguelas M-H, et al. Prevention of apoptotic and necrotic cell death, caspase-3 activation, and renal dysfunction by melatonin after ischemia/reperfusion. FASEB J. 2003;17:872-874.
68. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem. 1999;68:383-424.
69. Daemen MA, van de Ven MW, Heineman E, Buurman WA. Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation. 1999;67:792-800.
70. Lv X-X, Yu X-H, Wang H-D, et al. Berberine inhibits norepinephrine-induced apoptosis in neonatal rat cardiomyocytes via inhibiting ROS-TNF-a-caspase signaling pathway. Chin J Integr Med. 2013;19:424-431.
71. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med. 1997;3:614-620.
72. Adil M, Visnagri A, Kumar VS, Kandhare AD, Ghosh P. Protective effect of naringin on sodium arsenite induced testicular toxicity via modulation of biochernical perturbations in experimental rats. Pharmacologia. 2014;5:222-234.
73. Kandhare AD, Raygude KS, Ghosh P, et al. Effect of hydroalcoholic extract of Hibiscus rosa sinensis Linn. leaves in experimental colitis in rats. Asian Pac J Trop Biomed. 2012;5:337-344.
74. Goswami S, Kandhare A, Zanwar AA, et al. Oral l-glutamine administration attenuated cutaneous wound healing in Wistar rats. Int Wound J. 2014 [advance online publication]. doi: 10.1111/iwj. 12246.
75. Qian T, Nieminen AL, Herman B, Lemasters JJ. Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol. 1997;273:C1783-C1792.
76. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J. 1999;341:233-249.
77. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13:1899-1911.
78. Rouslin W. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol. 1983;244: H743-H748.